CD274 and non-small cell lung carcinoma: In agreement with this study, we found a highly significant association between the baseline percentage of HLA-DR+ CD14+ monocytic cells and objective responses in NSCLC patients under PD-L1/PD-1 blockade by high-dimensional flow cytometry in peripheral blood [45].